Home » Authors » Trista Morrison

Articles by Trista Morrison

Novalar Gets $30M D Round To Launch Dental Drug NV-101

Nov. 2, 2007

By Trista Morrison

Hana Stock Gets A Rise With $30M Loan Pact

Nov. 1, 2007

By Trista Morrison

Hana Stock Gets A Rise With $30M Loan Pact

Nov. 1, 2007

By Trista Morrison

Genoptix IPO Soars 56 percent; RXi Files For Independence

Oct. 31, 2007

By Trista Morrison

Neurobiological Offering Nets $56 Million For Viprinex Trials

Oct. 31, 2007

By Trista Morrison

Genoptix IPO Soars 56 percent; RXi Files For Independence

Oct. 31, 2007

By Trista Morrison

Neurobiological Offering Nets $56 Million For Viprinex Trials

Oct. 31, 2007

By Trista Morrison

With FDA Talks Stalled, Thallion Looks Abroad

Oct. 30, 2007

By Trista Morrison

With FDA Talks Stalled, Thallion Looks Abroad

Oct. 30, 2007

By Trista Morrison

NovaBay Prices IPO At $4/Share Gets $20M To Advance Pipeline

Oct. 29, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...